Delivery Order SPE2DB22D1002-SPE2DB25FKYK8
Award Date
2/20/25
Potential Completion Date
2/21/25
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,559.44 and an ultimate completion date of December 4, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $4,006.54 and a completion date of January 29, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen Drug Corp also holds...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award ceiling value is $1,084.38 and the contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5,...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, for a ceiling value of $1,248.84. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is February 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
This contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,478.39 and an ultimate completion date of December 9, 2024. The contract does not have a set-aside designation, indicating open...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a Defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,837.56 and a completion date of March 20, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $23,968.00 and an ultimate completion date of August 24, 2021. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc.,...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,722.10 with a firm fixed price. The contract has an ultimate completion date of November 1, 2024. This award is not associated with any set-aside requirements. Amerisourcebergen Drug Corp holds a $999,999,999...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $29,847.65 and is a firm fixed price delivery order. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 18, 2024. The contract has a ceiling value of $7,685.70 and is a firm fixed-price delivery order with an ultimate completion date of April 19, 2024. There is no set-aside designation for this...